PROGYNY INC (PGNY) Forecast, Price Target & Analyst Ratings
NASDAQ:PGNY • US74340E1038
17.91 USD
-0.34 (-1.86%)
At close: Mar 10, 2026
17.899 USD
-0.01 (-0.06%)
After Hours: 3/10/2026, 8:00:01 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for PROGYNY INC (PGNY).
Forecast Snapshot
Consensus Price Target
$30.79
+ 71.89% Upside
Next Earnings Forecast
Release DateMay 6, 2026
PeriodQ1 / 2026
EPS Estimate$0.25
Revenue Estimate341.95M
ChartMill Buy Consensus
83.53%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
$30.79
Upside
+ 71.89%
From current price of $17.91 to mean target of $30.79, Based on 17 analyst forecasts
Low
$26.26
Median
$30.60
High
$37.80
Price Target Revisions
1 Month
0.00%
3 Months
3.68%
Price Target Summary
17 Wall Street analysts provided a forecast for the next 12 months for PGNY. The average price target is 30.79 USD. This implies a price increase of 71.89% is expected in the next year compared to the current price of 17.91.
The average price target has been revised upward by 3.68% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
83.53%
PGNY was analyzed by 17 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about PGNY.
In the previous month the buy percentage consensus was at a similar level.
PGNY was analyzed by 17 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-05 | BTIG | Maintains | Buy -> Buy |
| 2026-03-02 | Keybanc | Maintains | Overweight -> Overweight |
| 2026-03-02 | Truist Securities | Maintains | Buy -> Buy |
| 2026-01-20 | Citizens | Upgrade | Market Perform -> Market Outperform |
| 2026-01-08 | Keybanc | Maintains | Overweight -> Overweight |
| 2025-12-09 | Barclays | Initiate | Overweight |
| 2025-11-17 | Canaccord Genuity | Maintains | Hold -> Hold |
| 2025-11-12 | Keybanc | Upgrade | Sector Weight -> Overweight |
| 2025-11-11 | JP Morgan | Maintains | Neutral -> Neutral |
| 2025-08-26 | JP Morgan | Maintains | Neutral -> Neutral |
| 2025-08-20 | Canaccord Genuity | Maintains | Hold -> Hold |
| 2025-08-08 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2025-07-17 | Truist Securities | Maintains | Hold -> Hold |
| 2025-07-08 | Leerink Partners | Upgrade | Market Perform -> Outperform |
| 2025-05-12 | Canaccord Genuity | Maintains | Hold -> Hold |
| 2025-03-31 | BTIG | Upgrade | Neutral -> Buy |
| 2025-02-28 | Canaccord Genuity | Maintains | Hold -> Hold |
| 2025-02-11 | B of A Securities | Maintains | Buy -> Buy |
| 2025-01-28 | JP Morgan | Maintains | Neutral -> Neutral |
| 2024-12-02 | JP Morgan | Downgrade | Overweight -> Neutral |
| 2024-11-14 | Barclays | Maintains | Overweight -> Overweight |
| 2024-11-13 | Truist Securities | Downgrade | Buy -> Hold |
| 2024-11-13 | Canaccord Genuity | Maintains | Hold -> Hold |
| 2024-11-13 | B of A Securities | Maintains | Buy -> Buy |
| 2024-10-01 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
Next Earnings Forecast Details
Next Earnings Details
Release DateMay 6, 2026
PeriodQ1 / 2026
EPS Estimate$0.25
Revenue Estimate341.95M
Revenue Q2Q5.53%
EPS Q2Q46.57%
Number of Analysts11
Next Earnings Revisions
Revenue (1 Month)
-3.77%
Revenue (3 Months)
-3.77%
EPS (1 Month)
8.57%
EPS (3 Months)
8.57%
Next Earnings Summary
PGNY is expected to report earnings on 5/6/2026. The consensus EPS estimate for the next earnings is 0.25 USD and the consensus revenue estimate is 341.95M USD.
The next earnings revenue estimate has been revised downward by 3.77% in the past 3 months.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.089B 38.34% | 1.167B 7.22% | 1.289B 10.40% | 1.412B 9.57% | 1.554B 10.06% | 1.635B 5.21% | 1.726B 5.57% | 1.718B -0.46% | 1.808B 5.24% | 1.899B 5.03% | |
| EBITDA YoY % growth | 64.465M 158.90% | 70.63M 9.56% | 95.825M 35.67% | 243.11M 153.70% | 273.57M 12.53% | 288.97M 5.63% | 285.6M -1.17% | 306M 7.14% | 326.4M 6.67% | 347.82M 6.56% | |
| EBIT YoY % growth | 62.184M 166.88% | 67.455M 8.48% | 90.877M 34.72% | 214.22M 135.73% | 237.34M 10.79% | 293.76M 23.77% | 270.3M -7.99% | 289.68M 7.17% | 310.08M 7.04% | 330.48M 6.58% | |
| Operating Margin | 5.71% | 5.78% | 7.05% | 15.17% | 15.27% | 17.97% | 15.66% | 16.86% | 17.15% | 17.40% | |
| EPS YoY % growth | 0.62 106.67% | 0.57 -8.06% | 0.65 14.04% | 1.05 62.10% | 1.24 17.72% | 1.66 33.63% | 2.45 47.69% | 2.17 -11.25% | 2.25 3.76% | 2.34 3.62% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.25 46.57% | 0.28 46.48% | 0.22 49.60% | 0.25 77.28% | 0.28 12.57% | 0.25 -10.21% | 0.27 20.45% | 0.24 -1.37% |
| Revenue Q2Q % growth | 341.95M 5.53% | 361.02M 8.46% | 355.99M 13.61% | 350.94M 10.22% | 404.5M 18.29% | 411.65M 14.02% | 401.16M 12.69% | 393.53M 12.14% |
| EBITDA Q2Q % growth | 58.127M 129.95% | 62.488M 134.29% | 62.344M 169.79% | 57.464M 106.19% | 73.033M 25.64% | 71.244M 14.01% | 71.129M 14.09% | 65.468M 13.93% |
| EBIT Q2Q % growth | 44.665M 84.80% | 47.999M 97.06% | 49.638M 154.20% | 45.624M 99.04% | 52.945M 18.54% | 48.394M 0.82% | 51.576M 3.90% | 46.467M 1.85% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
36.62%
EPS Next 5 Year
27.30%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
7.86%
Revenue Next 5 Year
5.69%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
9.76%
EBIT Next 5 Year
6.96%
PROGYNY INC / PGNY Forecast FAQ
What is the price target for PGNY stock?
17 analysts have analysed PGNY and the average price target is 30.79 USD. This implies a price increase of 71.89% is expected in the next year compared to the current price of 17.91.
Can you provide the upcoming earnings date for PROGYNY INC?
PROGYNY INC (PGNY) will report earnings on 2026-05-06.
What are the consensus estimates for PROGYNY INC (PGNY) next earnings?
The consensus EPS estimate for the next earnings of PROGYNY INC (PGNY) is 0.25 USD and the consensus revenue estimate is 341.95M USD.
Can you provide the expected long term growth rate for PROGYNY INC stock?
The expected long term growth rate for PROGYNY INC (PGNY) is 7.86%.